United Orthopedic Corporation (TPEX:4129)

Taiwan · Delayed Price · Currency is TWD

83.50

+1.10 (1.33%)

Sep 8, 2026, 11:14 AM CST

Market Cap	7.95B -28.3%
Revenue (ttm)	6.07B +19.1%
Net Income	551.16M +10.8%
EPS	5.51 +6.9%
Shares Out	96.44M
PE Ratio	14.97
Forward PE	12.68
Dividend	4.50 (5.54%)
Ex-Dividend Date	Jul 23, 2026

Volume	104,026
Open	82.80
Previous Close	82.40
Day's Range	82.80 - 83.70
52-Week Range	81.00 - 131.50
Beta	0.41
Analysts	Buy
Price Target	114.75 (+37.43%)
Earnings Date	Nov 10, 2026

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical equipment in Taiwan, Asia, America, Europe, Africa, and Oceania. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fractures, Moore hip prostheses, and customized artificial hip joints for individual tumor patients; artificial knee joints, including artificial knee replacement joints, revision knee replacement systems, restricted artificial knee joints, and customized artificial ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1993

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 4129

Full Company Profile

Financial Performance

In 2025, United Orthopedic's revenue was 5.66 billion, an increase of 21.54% compared to the previous year's 4.65 billion. Earnings were 562.02 million, an increase of 23.14%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 4129 stock is "Buy." The 12-month stock price target is $114.75, which is an increase of 37.43% from the latest price.

Price Target

$114.75

(37.43% upside)

Analyst Consensus: Buy

Stock Forecasts